Showing results (1-10 of 195) with videos related to
Sort By:
Pageof 20
Current Oncology (Toronto, Ont.)|September 26, 2025
Comment on Pang et al. Ablative Techniques for Lung Metastases: Patient Selection and Outcomes Following Treatment with Stereotactic Radiotherapy or Radiofrequency Ablation. <i>Curr. Oncol.</i> 2025, <i>32</i>, 303Fergus Macbeth, Tom TreasureThoracic Surgery Clinics|November 28, 2015
Is Surgery Warranted for Oligometastatic Disease?Tom Treasure, Fergus MacbethJournal of Cardiothoracic Surgery|November 19, 2014
An exception that proves the rule: recurrence free survival five years after extrapleural pneumonectomy for malignant pleural mesotheliomaTom Treasure, Fergus MacbethJournal of Thoracic Disease|May 20, 2021
Pulmonary metastasectomy: limits to credibilityTom Treasure, Fergus MacbethJournal of Clinical Medicine|December 17, 2024
Comments on Ambrogi et al. Lung Metastasectomy: Where Do We Stand? Results from an Italian Multicentric Prospective Database. <i>J. Clin. Med</i>. 2024, <i>13</i>, 3106Tom Treasure, Fergus MacbethJournal of Cardiothoracic Surgery|January 17, 2022
The full cohort of 512 patients and the nested controlled trial in 93 patients in the Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) study raise doubts about the effective size at present claimedTom Treasure, Norman R Williams, Fergus MacbethThorax|January 14, 2014
Pulmonary metastasectomy: what is the practice and where is the evidence for effectiveness?Tom Treasure, Mišel Milošević, Francesca Fiorentino, et al.Annals of Surgical Oncology|February 16, 2021
Randomised Controlled Trial Evidence Questions the Assumption that Pulmonary Metastasectomy Benefits Patients with Colorectal CancerTim Batchelor, Jurjees Hasan, Fergus Macbeth, et al.BMJ Open|May 15, 2014
The CEA Second-Look Trial: a randomised controlled trial of carcinoembryonic antigen prompted reoperation for recurrent colorectal cancerTom Treasure, Kathryn Monson, Francesca Fiorentino, et al.Pageof 20